维普中文期刊产品整合服务
31篇 您的检索式:作者名="BURKHOLDER I"
    题名 作者 年代 出处 被引量
1Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘Laack E Scheffler A Burkholder I 2005Lung Cancer2005,50,1:1
2Comparision of monostatic and bistatic radar iamges显示文摘BURKHOLDER R J GUPTA I J JOHNSON J T 2003Aerospace and Propagation Magazine2003,45,3:1
3Pretrcatment vascular endothelial growth factor (vegf) and matrix metallopruteinase-9 (mmp-9) serum levels in patients with metastatic non-small cell lung cancer (nsclc)显示文摘Laack E Scheffler A Burkholder I 2005Lung Cancer2005,50,:1
4Replication initiation proteins regulate a developmental checkpoint in Bacillus subtilis显示文摘BURKHOLDER W F KURTSER I GROSSMAN A D 2001Cell2001,104,2:1
5Pretreatment vascular endothelial growth factor(VEGF)and matrix metalloproteinase- 9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘Laak E Seheffler A Burkholder I 2005Lung Cancer2005,50,1:1
6Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) 显示文摘LAACK E SCHEFFLER A BURKHOLDER I 2005Lung Cancer2005,50,1:1
7Binding of recombinant misdetoe lectin (viscumin-e) to resectodhuman adenocarcinoma of the lung显示文摘Blonski K Schumacher U Burkholder I 2005Anticancer Res2005,25,5:1
8Comparison of mon- ostatie and bistatic radar images 显示文摘Burkholder R J Gupta I J Johnson J T 2003IEEE Antennas and Propogation Magazine2003,45,3:1
9Pretreatmentvascu- lar endothelial growth factor (VEGF) and matrix metallopro- teinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘Laack E Scheffler A Burkholder I 2005Lung Cancer2005,50,1:1
10Pretreatment vascular endothelial growth faetor(VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small cell lung cancer(NSCLC) 显示文摘LAACK E SCHEFFLER A BURKHOLDER I 2005Lung Cancer2005,50,1:1
11“ToxRTool” , a newtool to assess the reliability of toxicological data显示文摘Schneider K Schwarz M Burkholder I e t al 2009Toxicol L ett2009,189,2:1
12Comparison of Monostatic and Bistatie Adar Images显示文摘Burkholder R J Gupta I J Johnson J T 2003IEEE Antennas and Propogation Magazine2003,45,3:1
13Pretreatment vascular endothelial growth factor(VEGF)and matrix metallo proteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) 显示文摘Laack E Scheffler A Burkholder I 2005Lung Cancer2005,50,1:1
14Comparison of monostatic and bistatic radar images 显示文摘Burkholder R J Gupta I J Johnoson J T 2003IEEE Antennas and Propagation Magazine2003,45,3:1
15Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9 ( MMP-9 ) serum levels in patients with metastatic non-small cell lung cancer (NSCLC) 显示文摘Laack E Scheffler A Burkholder I 2005Lung Cancer2005,50,1:1
16Pretreatment vascularendothelial growth factor ( VEGF) and matrix metalloproteinase-9(MMP-9) serum levels in patients with metastatic non-small celllung cancer( NSCLC)显示文摘Laack E Scheffler A Burkholder I 2005Lung Cancer2005,50,1:1
17Replication initiation proteins regulate a developmental checkpoint in Bacillus subtilis显示文摘Burkholder W F Kurtser I Grossman A D 2001Cell2001,104,2:1
18Pretreatment vascular endothelial growth factor(VEGF) and matrix metalloproteinase-9(MMP-9)serum levels in patients with metastatic non-small cell lung cancer(NSCLC)显示文摘Laack E Scheffler A Burkholder I 0,,01:1
19Serum levels of magic roundabout protein in patients with advanced non-small cell lung cancer (NSCLC) 显示文摘Gorn M Anige M Burkholder I 2005Lung Cancer2005,49,1:1
20The prune belly syndrome显示文摘Williams D I Burkholder G V 1967J Urol1967,98,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费